Form 8-K - Current report:
SEC Accession No. 0001641172-25-018467
Filing Date
2025-07-10
Accepted
2025-07-09 17:32:05
Documents
13
Period of Report
2025-07-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53817
2 EX-3.1 ex3-1.htm EX-3.1 154234
  Complete submission text file 0001641172-25-018467.txt   407521

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mgrx-20250703.xsd EX-101.SCH 3032
4 XBRL LABEL FILE mgrx-20250703_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE mgrx-20250703_pre.xml EX-101.PRE 22370
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3965
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 251114399
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)